Alternatives to Bristol Myers Squibb

Biotechnology company developing novel immunotherapies for cancer.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Immunotherapy company targeting oncology and autoimmune diseases.

Biopharmaceutical company focused on developing orally administered therapeutics for inflammatory disorders and cancer.

Developing immunotherapeutic bi-functional fusion proteins to harness the immune system against cancer.

A global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.